Drug Infusion Systems Market Overview Highlighting Major Drivers, Size, Share, and Demand Report 2021- 2028

Drug Infusion Systems Market

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1%, during the forecast period, according to latest analysis by Emergen Research. Increasing demand for safe and precise drug delivery systems is a key driver expected to drive global drug infusion systems market revenue growth over the forecast period. Increasing application of drug infusion systems for chronic pain management is expected to further propel revenue growth of the global drug infusion systems market in the near future. Increasing integration of advanced equipment and up-gradation of drug infusion systems, such as flow monitoring and microflow regulators, is expected to boost global drug infusion systems market revenue growth going ahead.

However, lack of skilled healthcare professional to operate drug infusion systems is expected to hamper growth of the global drug infusion systems market to a certain extent over the forecast period.

Get a sample of the report @ https://www.emergenresearch.com/request-sample/692

Some Key Highlights From the Report

• The open-loop system segment revenue is expected to expand at a significant CAGR during the forecast period. Increasing usage of drug infusion systems with the open-loop system across hospitals is expected to boost revenue growth of this segment going ahead.
• The continuous infusion segment is expected to lead in terms of revenue over the forecast period due to increasing usage of continuous infusion type-based drug infusion systems among end-users.
• Factors such as rising prevalence of chronic diseases and increasing adoption of technologically advanced medical equipment in the healthcare industry in countries in North America is expected to drive growth of the market in the region during the forecast period.
• Key players in the market include Medtronic plc, Arcomed Ag, Baxter International Inc., Insulet Corporation, Smiths Group plc, Becton, Dickinson and Company, Halyard Health, Inc., ICU Medical, Inc., Flowonix Medical Inc., and Zyno Medical LLC
• In February 2020, Abbott Laboratories announced a partnership with Insulet Corporation. Abbott integrates the next-generation Continuous Glucose Monitoring (CGM) technology with the Omnipod Horizon Automated Insulin Delivery System from Insulet. This partnership would result in streamlined, personalized diabetes care for insulin users. Glucose data from our FreeStyle Libre next-generation sensor will be sent directly to the Omnipod Horizon pod to regulate insulin delivery automatically.

Emergen Research has segmented the global drug infusion systems market on the basis of control systems, infusion type, administration route, application, end-use, and region:

• Control Systems Outlook (Revenue, USD Billion; 2018–2028)
o Open Loop System
o Closed Loop System
• Infusion Type Outlook (Revenue, USD Billion; 2018–2028)
o Continuous Infusion
o Intermittent Infusion
o Patient Controlled Infusion
o Total Parenteral Nutrition
• Administration Route Outlook (Revenue, USD Billion; 2018–2028)
o Enteral
o Subcutaneous
o Intravenous
o Arterial
o Epidural
• Application Outlook (Revenue, USD Billion; 2018–2028)
o Pediatrics
o Diabetes
o Nutrition
o Hematology
o Analgesia
o Chemotherapy
o Others
• End-Use Outlook (Revenue, USD Billion; 2018–2028)
o Diagnostic Centers
o Hospitals
o Ambulatory Surgical Centers
o Others

Request customization of the report @ https://www.emergenresearch.com/request-for-customization/692

The report further covers extensive regional analysis of the Drug Infusion Systems industry with regards to market scope, market size, market share, revenue generation, production and consumption ratio, supply and demand ratio, and analysis of the key players operating in those regions. The regional analysis covers North America, Europe, AsiaPacific, Latin America, and Middle East & Africa.

Key questions answered in the Report:

• What are the key driving factors of the Drug Infusion Systems industry?
• Which segment and sub-segment are expected to show significant growth during the forecast period?
• What will the market size and growth rate be throughout the forecast period?
• Who are the prominent players of the Drug Infusion Systems industry?
• What are the technological advancements and product developments taking place in the Drug Infusion Systems market?
• Which region is expected to dominate the market in the coming years?
• What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?
• What are the key risk factors and challenges the companies will face in the market?
• What factors are expected to hinder the growth of the Drug Infusion Systems industry?

Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2021–2028
Chapter 3. Key Insights
Chapter 4. Drug Infusion Systems Market Segmentation & Impact Analysis
4.1. Drug Infusion Systems Market Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing demand for safe and precise drug delivery systems
4.2.2.2. Increasing application of drug infusion system for chronic pain management
4.2.2.3. Increasing prevalence of diabetes globally
4.2.2.4. Rising demand for drug infusion system to control hemodynamics
4.2.3. Market restraints analysis
4.2.3.1. High cost of drug infusion system
4.2.3.2. Lack of skilled healthcare professional to operate drug infusion systems
4.2.3.3. Stringent government regulations for product approval
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Drug Infusion Systems Market By Control Systems Insights & Trends, Revenue (USD Billion)
5.1. Control Systems Dynamics & Market Share, 2021–2028
5.1.1. Open Loop System
5.1.2. Closed Loop System
CONTINUED…!

To read more about the report, visit @ https://www.emergenresearch.com/industry-report/drug-infusion-systems-market

Thank you for reading our report. Customization of the report is available based on the client’s requirements. For more details, kindly connect with us, and our team will ensure the report is suited to meet your requirements.

Read similar reports by Emergen Research:

Virtual Diagnostics Market@ https://www.google.ge/url?q=https://www.emergenresearch.com/industry-report/virtual-diagnostics-market

3D Printing Healthcare Market@ https://www.google.com.gh/url?q=https://www.emergenresearch.com/industry-report/3d-printing-healthcare-market

Spherical Graphite Market@ https://www.google.com.gi/url?q=https://www.emergenresearch.com/industry-report/spherical-graphite-market

Digital Biomarkers Market@ https://www.google.gr/url?q=https://www.emergenresearch.com/industry-report/digital-biomarkers-market

Sodium Dichromate Market@ https://www.google.gl/url?q=https://www.emergenresearch.com/industry-report/sodium-dichromate-market

Contact Us:

Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.